13F Holdings
中文EN

FEED ENvue Medical, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1326706 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-17.7%
TTM net income YoY-154.6%
TTM EPS YoY72.9%
Revenue 3-yr CAGR44.2%
Net income 3-yr CAGR—

Margins

Gross margin-26.1%
Operating margin-1,362.7%
Net margin-1,093.6%
FCF margin-609.8%
EBITDA margin-1,313.3%

Returns

ROE-59.1%
ROA-46.9%
ROIC (approx.)-62.7%
Asset turnover0.04x

Leverage & solvency

Liabilities / assets19.9%
Debt / equity0.00x
Current ratio0.66x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.55x
Accruals ratio-20.9%
Payout ratio—
Capex / revenue4.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.55M$2.56M$2.28M$752,000$1.70M
Cost of revenue$2.40M$1.05M$746,000$585,000$925,000
Gross profit$153,000$1.51M$1.54M$167,000$770,000
R&D expense$1.76M$909,000$185,000$283,000$293,000
SG&A expense$7.63M$3.46M$3.92M$3.93M$5.06M
Operating income-$22.89M-$3.58M-$3.44M-$5.01M-$5.68M
Interest expense—$135,000$135,000$347,000—
Pretax income-$18.49M-$3.69M-$3.68M-$5.41M-$14.25M
Income tax-$307,000$19,000$29,000$35,000$32,000
Net income-$18.18M-$3.71M-$3.71M-$5.45M-$14.28M
EBITDA-$21.99M-$3.58M-$3.44M-$5.01M-$5.68M
EPS (basic)-26.69-137.30-23.32-3.84-11.35
EPS (diluted)-26.69-137.30-23.32-3.84-0.57
Weighted avg. shares (diluted)628,53426,985159,1051.42M25.16M
Balance sheet
Cash & equivalents$4.22M$752,000$3.28M$2.71M$7.74M
Receivables$289,000$98,000$318,000$9,000$200,000
Inventory$2.34M$2.19M$2.73M$2.17M$175,000
Current assets$7.27M$3.33M$6.49M$5.61M$8.34M
PP&E, net$119,000$9,000$7,000$7,000$5,000
Goodwill$29.08M————
Intangibles$4.38M————
Total assets$41.12M$3.63M$6.67M$5.88M$8.62M
Current liabilities$6.66M$2.72M$2.45M$2.32M$1.90M
Total liabilities$7.63M$3.00M$2.69M$2.65M$2.31M
Shareholders' equity$33.50M$627,000$3.99M$3.23M$6.31M
Shares outstanding1.10M37,894186,0281.64M1.40M
Cash flow statement
Operating cash flow-$9.37M-$2.52M-$3.60M-$7.04M-$4.37M
Capital expenditure$60,000$3,000$1,000$3,000$3,000
Free cash flow-$9.43M-$2.52M-$3.60M-$7.04M-$4.37M
Investing cash flow$88,000-$3,000-$1,000-$3,000-$3,000
Financing cash flow$12.79M$1,000$4.22M$2.09M$4.58M
Depreciation & amortization$897,000$1,000$1,000$1,000$2,000
Stock-based compensation—$356,000$293,000$354,000$382,000

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.